Benzinga - by Avi Kapoor, Benzinga Staff Writer.
Shares of Doma Holdings Inc. (NYSE: DOMA) rose sharply in today’s pre-market trading after the company entered a merger transaction with TRG to go private at $6.29 per share in cash.
Doma Holdings shares jumped 34.1% to $6.09 in pre-market trading
Here are some other stocks moving in pre-market trading.
Gainers
- Vast Renewables Limited (NASDAQ: VSTE) rose 213.9% to $9.70 in pre-market trading after jumping 39% on Thursday.
- MediaCo Holding Inc. (NASDAQ: MDIA) gained 84% to $0.9601 in pre-market trading after dipping more than 17% on Thursday.
- Galera Therapeutics, Inc. (NASDAQ: GRTX) gained 49.5% to $0.2093 in pre-market trading. Galera Therapeutics posted fourth-quarter results on Thursday.
- Qilian International Holding Group Limited (NASDAQ: QLI) shares gained 32.2% to $0.8399 in pre-market trading.
- Sunshine Biopharma, Inc. (NASDAQ: SBFM) gained 30.7% to $0.0791 in pre-market trading after the company reported operating results for the fiscal year ended Dec. 31, 2023.
- Xilio Therapeutics, Inc. (NASDAQ: XLO) shares rose 26.8% to $1.37 in pre-market trading. Xilio Therapeutics shares jumped 69% on Thursday after the company announced an exclusive license agreement with Gilead Sciences for a tumor-activated IL-12 program.
- Zapata Computing Holdings Inc. (NASDAQ: ZPTA) gained 10.3% to $15.01 in pre-market trading.
- Torrid Holdings Inc. (NYSE: CURV) shares rose 13.9% to $5.5579 in pre-market trading after the company reported better-than-expected fourth-quarter financial results.
- PAVmed Inc. (NASDAQ: PAVM) climbed 8% to $2.31 in pre-market trading after dipping over 20% on Thursday.
- Mountain Crest Acquisition Corp. IV (NASDAQ: MCAF) fell 58.7% to $5.99 pre-market trading. CH Auto Technology and Mountain Crest Acquisition Corp. IV completed transformative business combination.
- Fractyl Health, Inc. (NASDAQ: GUTS) declined 28.9% to $5.26 in pre-market trading after the company received FDA IDE approval for Revita Remain-1 study for obesity after discontinuation of GLP-1 based drugs. The company also reported fourth-quarter results.
- ENDRA Life Sciences Inc. (NASDAQ: NDRA) shares dropped 28.3% to $0.4157 in pre-market trading after the company reported fourth-quarter results.
- X3 Holdings Co Ltd. (NASDAQ: XTKG) fell 28.1% to $0.7118 in pre-market trading after the company unveiled its strategic partnership with a leading provider of semiconductor modules and devices..
- Sintx Technologies, Inc. (NASDAQ: SINT) fell 22.8% to $0.0382 in pre-market trading after announcing a proposed public offering of common stock.
- Vivos Therapeutics, Inc. (NASDAQ: VVOS) fell 18.8% to $3.9220 pre-market trading after reporting quarterly results.
- Avalo Therapeutics, Inc. (NASDAQ: AVTX) fell 16.4% to $18.19 in pre-market trading following FY2023 results.
- Applied Therapeutics, Inc. (NASDAQ: APLT) shares tumbled 14.7% to $5.80 in pre-market trading after the company announced that the FDA extended the review period for the NDA for govorestat for the treatment of Classic Galactosemia by three months.
- CleanSpark, Inc. (NASDAQ: CLSK) shares fell 12.3% to $18.60 in pre-market trading after declining over 8% on Thursday. Cantor Fitzgerald analyst Josh Siegler maintained Cleanspark with an Overweight and raised the price target from $10 to $20 on Thursday.
- Oxford Industries, Inc. (NYSE: OXM) fell 6% to $105.68 in pre-market trading as the company reported downbeat financial results for its fourth quarter and issued weak guidance for the first quarter.
Now Read This: Top 2 Energy Stocks That Are Preparing To Pump In April
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.